Literature DB >> 19088183

Mitochondrial dysfunction in mut methylmalonic acidemia.

Randy J Chandler1, Patricia M Zerfas, Sara Shanske, Jennifer Sloan, Victoria Hoffmann, Salvatore DiMauro, Charles P Venditti.   

Abstract

Methylmalonic acidemia is an autosomal recessive inborn error of metabolism caused by defective activity of methylmalonyl-CoA mutase (MUT) that exhibits multiorgan system pathology. To examine whether mitochondrial dysfunction is a feature of this organic acidemia, a background-modified Mut-knockout mouse model was constructed and used to examine mitochondrial ultrastructure and respiratory chain function in the tissues that manifest pathology in humans. In parallel, the liver from a patient with mut methylmalonic acidemia was studied in a similar fashion. Megamitochondria formed early in life in the hepatocytes of the Mut(-/-) animals and progressively enlarged. Liver extracts prepared from the mutants at multiple time points displayed respiratory chain dysfunction, with diminished cytochrome c oxidase activity and reduced intracellular glutathione compared to control littermates. Over time, the exocrine pancreas and proximal tubules of the kidney also exhibited megamitochondria, and older mutant mice eventually developed tubulointerstitial renal disease. The patient liver displayed similar morphological and enzymatic findings as observed in the murine tissues. These murine and human studies establish that megamitochondria formation with respiratory chain dysfunction occur in a tissue-specific fashion in methylmalonic acidemia and suggest treatment approaches based on improving mitochondrial function and ameliorating the effects of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088183      PMCID: PMC2660647          DOI: 10.1096/fj.08-121848

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  45 in total

Review 1.  Methylmalonic and propionic acidaemias: management and outcome.

Authors:  H Ogier de Baulny; J F Benoist; O Rigal; G Touati; D Rabier; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Differential inhibitory effects of methylmalonic acid on respiratory chain complex activities in rat tissues.

Authors:  Leticia F Pettenuzzo; Gustavo da C Ferreira; Anna Laura Schmidt; Carlos S Dutra-Filho; Angela T S Wyse; Moacir Wajner
Journal:  Int J Dev Neurosci       Date:  2006-02       Impact factor: 2.457

3.  Combined liver-kidney transplantation in methylmalonic acidemia.

Authors:  W G van 't Hoff; M Dixon; J Taylor; P Mistry; K Rolles; L Rees; J V Leonard
Journal:  J Pediatr       Date:  1998-06       Impact factor: 4.406

4.  Management of methylmalonic acidaemia by combined liver-kidney transplantation.

Authors:  S Nagarajan; G M Enns; M T Millan; S Winter; M M Sarwal
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

5.  Increased hepatic mitochondrial capacity in rats with hydroxy-cobalamin[c-lactam]-induced methylmalonic aciduria.

Authors:  S Krahenbuhl; D B Ray; S P Stabler; R H Allen; E P Brass
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Glutathione deficiency as a complication of methylmalonic acidemia: response to high doses of ascorbate.

Authors:  E Treacy; L Arbour; P Chessex; G Graham; L Kasprzak; K Casey; L Bell; O Mamer; C R Scriver
Journal:  J Pediatr       Date:  1996-09       Impact factor: 4.406

7.  Neurological outcome of methylmalonic acidaemia.

Authors:  P Nicolaides; J Leonard; R Surtees
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

8.  Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia.

Authors:  S B van der Meer; F Poggi; M Spada; J P Bonnefont; H Ogier; P Hubert; E Depondt; D Rapoport; D Rabier; C Charpentier
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

9.  Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice.

Authors:  M D Williams; H Van Remmen; C C Conrad; T T Huang; C J Epstein; A Richardson
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

10.  Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.

Authors:  R M Lebovitz; H Zhang; H Vogel; J Cartwright; L Dionne; N Lu; S Huang; M M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  67 in total

1.  FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia.

Authors:  Irini Manoli; Justin R Sysol; Madeline W Epping; Lina Li; Cindy Wang; Jennifer L Sloan; Alexandra Pass; Jack Gagné; Yiouli P Ktena; Lingli Li; Niraj S Trivedi; Bazoumana Ouattara; Patricia M Zerfas; Victoria Hoffmann; Mones Abu-Asab; Maria G Tsokos; David E Kleiner; Caterina Garone; Kristina Cusmano-Ozog; Gregory M Enns; Hilary J Vernon; Hans C Andersson; Stephanie Grunewald; Abdel G Elkahloun; Christiane L Girard; Jurgen Schnermann; Salvatore DiMauro; Eva Andres-Mateos; Luk H Vandenberghe; Randy J Chandler; Charles P Venditti
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia.

Authors:  Daniela R Melo; Alicia J Kowaltowski; Moacir Wajner; Roger F Castilho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

Review 3.  Advances in high-resolution imaging--techniques for three-dimensional imaging of cellular structures.

Authors:  Diane S Lidke; Keith A Lidke
Journal:  J Cell Sci       Date:  2012-06-08       Impact factor: 5.285

4.  Variable dietary management of methylmalonic acidemia: metabolic and energetic correlations.

Authors:  Natalie S Hauser; Irini Manoli; Jennifer C Graf; Jennifer Sloan; Charles P Venditti
Journal:  Am J Clin Nutr       Date:  2010-11-03       Impact factor: 7.045

5.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.

Authors:  Stefan Kölker; Angeles Garcia-Cazorla; Angeles Garcia Cazorla; Vassili Valayannopoulos; Allan M Lund; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Persephone Augoustides-Savvopoulou; Lise Aksglaede; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Veronika Dvorakova; Francesca Furlan; Florian Gleich; Wanda Gradowska; Stephanie Grünewald; Anil Jalan; Johannes Häberle; Gisela Haege; Robin Lachmann; Alexander Laemmle; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Hélène Ogier de Baulny; Carlos Ortez; Luis Peña-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Christian Staufner; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

6.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.

Authors:  Stefan Kölker; Vassili Valayannopoulos; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; S P Nikolas Boy; Marlene Bøgehus Rasmussen; Peter Burgard; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Francesca Furlan; Florian Gleich; Maria Julieta González; Wanda Gradowska; Stephanie Grünewald; Tomas Honzik; Friederike Hörster; Hariklea Ioannou; Anil Jalan; Johannes Häberle; Gisela Haege; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Elaine Murphy; Hélène Ogier de Baulny; Carlos Ortez; Consuelo C Pedrón; Guillem Pintos-Morell; Luis Pena-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Allan M Lund; Angeles Garcia-Cazorla; Angeles Garcia Cazorla
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

Review 7.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

8.  Methylmalonic aciduria cblB type: characterization of two novel mutations and mitochondrial dysfunction studies.

Authors:  S Brasil; E Richard; A Jorge-Finnigan; F Leal; B Merinero; R Banerjee; L R Desviat; M Ugarte; B Pérez
Journal:  Clin Genet       Date:  2014-06-06       Impact factor: 4.438

Review 9.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

10.  Spectrum of Mutations in 60 Saudi Patients with Mut Methylmalonic Acidemia.

Authors:  Faiqa Imtiaz; Bashayer M Al-Mubarak; Abeer Al-Mostafa; Mohamed Al-Hamed; Rabab Allam; Zuhair Al-Hassnan; Mohammed Al-Owain; Hamad Al-Zaidan; Zuhair Rahbeeni; Alya Qari; Eissa Ali Faqeih; Ali Alasmari; Fuad Al-Mutairi; Majid Alfadhel; Wafaa M Eyaid; Mohamed S Rashed; Moeenaldeen Al-Sayed
Journal:  JIMD Rep       Date:  2015-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.